Studies of patients with psychogenic non-epileptic seizures (NES) typically focus upon the phenomenology and outcome of NES episodes. Little is known, however, about the frequency and nature of other somatic symptoms such as pain, in this population. To assess the frequency, location and severity of symptoms of pain among NES patients, we administered structured interviews to 56 patients, 6 or more months following the diagnosis of psychogenic non-epileptic seizures (NES). Patients were recruited from a tertiary hospital-based epilepsy monitoring unit. Seventy-seven percent of patients suffered from moderate to severe pain, most commonly headache (61%), while neck pain and backache were also common. Twenty-six of 27 patients with persistent NES vs. 17 of 29 patients whose NES resolved experienced moderate to severe pain (P < 0.001). Pain is an under-recognized problem that occurs frequently and with significant severity among NES patients. Pain symptoms are more common among patients with persistent NES than those whose NES resolve.
INTRODUCTION
Psychogenic non-epileptic seizures (NES) are clinical events that resemble epileptic attacks but are not associated with physiologic central nervous system dysfunction 1, 2 . While numerous NES studies 3, 4 have focused upon the phenomenology of non-epileptic attacks, few investigations have examined the frequency and nature of other conversion symptoms in this population. Such symptoms need to be recognized since they may impair occupational and social function and quality of life. NES patients classified as having a good prognosis based on resolution or improved NES frequency may in fact have a poor outcome if other significant symptoms persist. Our goal, therefore, was to assess the frequency, location and severity of one type of somatic symptom (pain) in this population, and to determine how commonly moderate to severe pain occurs even in patients whose NES has resolved or improved.
MATERIALS AND METHODS
Details of methodology were described previously 5 in another report that examined other variables among our NES patients. A brief summary of the methods follows.
Population
We identified patients over the age of 12 years, diagnosed with NES between the dates of 1990 and 1996 at the New York University Hospital for Joint Diseases Comprehensive Epilepsy Center. The NES diagnosis was based on a comprehensive neurological and psychiatric evaluation as well as video-EEG monitoring that captured characteristic episodes during the recording. Episodes identified as NES were not associated with electroencephalographic seizure correlate nor post-ictal prolactin elevation, and were clinically atypical for epileptic seizures 3, 6 . All patients in this study were diagnosed as having a conversion disorder; none had factitious disorder or malingering. The diagnosis of NES was presented during the hospital stay (>90%) or at the first outpatient follow-up visit (<10%) by the attending neurologist as previously described 7, 8 . The discussion stressed patient dignity, emphasizing that the disorder is 'serious and real' but different than epilepsy.
We uniformly recommended further evaluation and treatment by a psychotherapist or psychiatrist. Most patients were returned to the original health care provider with arrangements for local psychotherapy and psychopharmacologic intervention as indicated.
We excluded patients who had:
(1) Episodes suggestive of possible current or past epileptic seizures (e.g. patients with episodes associated with major body injuries).
(2) Episodes captured on video-EEG that were not typical of the usual episodes described by the patient. 
Testing
Six or more months after patients received the NES diagnosis, we contacted patients who met study criteria. All study patients signed an institutional review board-approved consent form and agreed to undergo a telephone-based structured interview. NES outcome was defined as 'resolved' (episodefree), or persistent (all others).
In the current study, we asked patients whether they suffer from pain symptoms that were significant enough to seek medical attention, persistent (lasting more than several months) and occurring near the time of NES diagnosis and/or follow-up. We inquired about the location of the pain and asked patients to rate the pain as mild, moderate or severe.
Statistics
We used the Fisher exact two-tailed test to assess the relationship of NES outcome with pain symptoms.
RESULTS
Seventy-six patients met study criteria. Eight patients could not be reached, two died (neither due to suicide) and 10 declined to participate, leaving 56 patients: 16 (28.6%) male; 40 (71.4%) female who entered the study. Mean duration of follow-up was 17.9 months (SD = ±10.6 months). Mean age at the time of NES diagnosis was 33 years (range 12-58 years; SD = ±12 years); mean age at follow-up was 34.73 years (range 14-61 years; SD = ±11.9 years). Mean age of NES onset was 27.8 years (range 9-58 years; SD = ±12.6). Mean NES duration was 8 years (range 1-38 years; SD = ±8.9).
NES outcome and patients' descriptions about pain symptoms are displayed in Table 1 . The majority of patients had some type of pain symptom; 77% reported moderate to severe levels of pain. Headache was the single most common type of pain; backache and neck pain were the second and third most common pain symptom, respectively. Fifty-nine percent of patients whose NES resolved and 96% of patients with persistent NES experienced moderate to severe pain of one or more locations. Twenty-six of 27 patients with persistent NES vs. 17 of 29 patients whose NES resolved experienced moderate to severe pain (P < 0.001). Among 29 patients with abolished NES, 13 (44.8%) had a single location for pain vs. 16 (55.2%) had multiple pain symptoms. Among 27 patients with persistent NES, 14 (51.9%) had a single location for pain vs. 13 (28.1%) with multiple pain symptoms (P = NS).
DISCUSSION
We found chronic pain symptoms of moderate to severe intensity occurred in more than three-quarters of NES patients. Headache, backache, neck pain and other pain syndromes were present in decreasing order of frequency. These patients all sought medical treatment for these symptoms and in many cases underwent extensive diagnostic studies, therapeutic trials, and in some cases, surgery. The high frequency of these symptoms in patients with NES and the higher frequency in patients with persistent NES, suggest that some symptoms may result from psychological mechanisms.
The pathogenesis of pain symptoms in NES patients remains poorly defined. In some cases, physiologic disorders (e.g. migraine, central pain) or structural lesions (e.g. lumbar disc herniation, endometriosis) can cause chronic disabling pain. However, the high frequency of refractory pain syndromes especially among patients with persistent NES, suggests that in some cases psychological factors were a contributing or predominant cause. Future studies should assess rates of pain symptoms in patients with NES compared to other disorders.
DSM-IV categorizes conversion disorder within the family of Somatoform Disorders. Somatoform disorders are characterized by physical symptoms that mimic medical or neurologic disease but are not fully explainable by a medical or neurologic condition and are not due to substance abuse or another mental disorder. In addition to conversion disorder, other somatoform disorders include Somatization Disorder, Undifferentiated Somatoform Disorder, Pain Disorder, and Hypochondriasis. The predominant feature of somatoform disorders is pain or discomfort. Among the criteria for Somatization Disorder, four pain symptoms must be present. Given the central role of pain in somatoform disorders, one would suspect a high frequency of psychogenic pain symptoms in patients with any somatoform disorder, including conversion NES.
Bowman and Markand 11 also found severe, unexplained headaches were common in their NES series. We previously reported four patients with refractory basilar artery migraine who underwent video-EEG recording to exclude epilepsy and whose neurologic symptoms and headaches were conversion symptoms 12 . Currently, somatoform disorders are infrequently diagnosed in patients with chronic headache. In large measure, this may result from the lack of a clear diagnostic test. Similarly, prior to the widespread use of video-EEG monitoring, NES were diagnosed much less frequently 13 . We speculate that many cases of chronic headache, back pain and other neurogenic pain syndromes due primarily to a somatoform disorder go unrecognized. Further, many patients with NES may have coexistent somatoform symptoms that are inappropriately treated. For example, one of the NES patients in this series had more than six abdominal surgeries for pain but a review of operative notes and pathology reports failed to identify a clear pathogenic process (other than adhesions found in the latter two surgeries, likely a result of earlier surgery).
Our study suggests that future investigations should be performed to determine what effect revealing NES diagnosis has on the frequency and severity of headache and other pain symptoms. In some patients, resolution of the NES may be followed by the development of substitute symptoms of pain. Prospective studies are needed to better screen for patients at risk, and identify the frequency of symptom substitution. Our study should also inspire future examinations of other types of symptoms, since in some patients, NES may not be the most serious manifestation of their somatoform disorder.
